Saniona AB - Product Pipeline Review - 2016

  • ID: 3845360
  • Company Profile
  • 55 pages
  • Global Markets Direct
1 of 4
Saniona AB - Product Pipeline Review - 2016

Summary

‘Saniona AB - Product Pipeline Review - 2016’, provides an overview of the Saniona AB’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Saniona AB, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Saniona AB
- The report provides overview of Saniona AB including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Saniona AB’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Saniona AB’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Saniona AB’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Saniona AB
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Saniona AB’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Saniona AB Snapshot

Saniona AB Overview

Key Information

Key Facts

Saniona AB - Research and Development Overview

Key Therapeutic Areas

Saniona AB - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Saniona AB - Pipeline Products Glance

Saniona AB - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Saniona AB - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Saniona AB - Drug Profiles

(metoprolol + tesofensine)

Product Description

Mechanism of Action

R&D Progress

NS-2359

Product Description

Mechanism of Action

R&D Progress

tesofensine

Product Description

Mechanism of Action

R&D Progress

AN-721

Product Description

Mechanism of Action

R&D Progress

AN-788

Product Description

Mechanism of Action

R&D Progress

AN-346

Product Description

Mechanism of Action

R&D Progress

AN-470

Product Description

Mechanism of Action

R&D Progress

AN-761

Product Description

Mechanism of Action

R&D Progress

NS-9283

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Agonize GABAA Alpha 2 and Alpha 3 for Neuropathic Pain

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Agonize nAChR Alpha7 for Pain and Alzheimer's Disease

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Activate Kv7.2 and Kv7.3 Channels for Epilepsy and Pain

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Activate TREK for Pain

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Agonize GABA Alpha 4 Delta Receptor for Sleep Disorders, Stress and Autism

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Agonize GABAA Receptor Subunit Alpha-4 and Gamma for Epilepsy

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Agonize GABAA Receptor Subunit Alpha-5 for Autism

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Agonize nAChR Alpha6 for Parkinson's Disease

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Block TREK for Depression

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit Monoamine Reuptake for Pain

Product Description

Mechanism of Action

R&D Progress

Saniona AB - Pipeline Analysis

Saniona AB - Pipeline Products by Target

Saniona AB - Pipeline Products by Route of Administration

Saniona AB - Pipeline Products by Molecule Type

Saniona AB - Pipeline Products by Mechanism of Action

Saniona AB - Recent Pipeline Updates

Saniona AB - Dormant Projects

Saniona AB - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

NS-2359

tesofensine

Saniona AB - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Saniona AB, Key Information

Saniona AB, Key Facts

Saniona AB - Pipeline by Indication, 2016

Saniona AB - Pipeline by Stage of Development, 2016

Saniona AB - Monotherapy Products in Pipeline, 2016

Saniona AB - Combination Treatment Modalities in Pipeline, 2016

Saniona AB - Out-Licensed Products in Pipeline, 2016

Saniona AB - Out-Licensed Products/ Combination Treatment Modalities, 2016

Saniona AB - Phase II, 2016

Saniona AB - Phase I, 2016

Saniona AB - Preclinical, 2016

Saniona AB - Discovery, 2016

Saniona AB - Pipeline by Target, 2016

Saniona AB - Pipeline by Route of Administration, 2016

Saniona AB - Pipeline by Molecule Type, 2016

Saniona AB - Pipeline Products by Mechanism of Action, 2016

Saniona AB - Recent Pipeline Updates, 2016

Saniona AB - Dormant Developmental Projects,2016

Saniona AB - Discontinued Pipeline Products, 2016 52List of Figures

Saniona AB - Pipeline by Top 10 Indication, 2016

Saniona AB - Pipeline by Stage of Development, 2016

Saniona AB - Monotherapy Products in Pipeline, 2016

Saniona AB - Combination Treatment Modalities in Pipeline, 2016

Saniona AB - Pipeline by Top 10 Target, 2016

Saniona AB - Pipeline by Route of Administration, 2016

Saniona AB - Pipeline by Molecule Type, 2016

Saniona AB - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll